The Diabetes Epidemic
What is Diabetes?
Diabetes occurs when the body can no longer produce insulin or cannot make good use of the insulin it creates. Insulin is essential for the body to utilise glucose from food for energy. Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood, known as hyperglycaemia. Over the long term, high glucose levels are associated with damage to the body and failure of various organs and tissues.
Type 1 diabetes results from an auto-immune disorder where the body’s defence system attacks the insulin-producing cells in the pancreas, resulting in an inability to produce insulin. Type 2 diabetes develops from environmental, lifestyle, and genetic predisposition factors. People with Type 2 diabetes might produce insulin; however, they do not have enough for the body to function adequately, or cells are resistant to insulin’s effects.
The Largest Diabetes Epidemic
An estimated 260 million people will be living with diabetes in Asia Pacific by 2045.
Asia Pacific has over one third of the world's total population of living with diabetes.
Diabetes and complications from diabetes contributed to 2.3 million deaths in Asia Pacific in 2021.
There are 109 million undiagnosed cases of diabetes in Asia Pacific.
A Global Epidemic
people with diabetes worldwide by 2045
currently live with diabetes
adults are at increased risk of developing type 2 diabetes
We're Addressing the Challenges
of Invasive Glucose Monitoring
Glucose monitoring is critical for people living with diabetes to sustain good health. Currently, the only approved methods for testing glucose levels are painful and invasive. As a result, many people with diabetes do not test as often as clinically recommended, increasing the risk of complications.
Download our industry paper to learn more about:
- the challenges of current glucose monitoring technologies
- the urgent need for non-invasive glucose monitoring
- how non-invasive glucose monitoring will help millions of people with diabetes
The Saliva Glucose Biosensor
Our technology has the potential to replace the need for finger-prick blood glucose testing.
* For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction.
Place the Saliva Glucose Biosensor in contact with saliva.
A digital app displays the glucose measurement, flagging any data that needs attention.
The app provides real-time comparisons with historical data and sends data to an electronic medical record or caregiver.